H. Lundbeck A/S header image

H. Lundbeck A/S

HLUN A

Equity

ISIN DK0061804697 / Valor 119252584

Nasdaq Copenhagen Equities (2026-04-01)

DKK 34.00+1.80%

H. Lundbeck A/S
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

H. Lundbeck A/S is a global pharmaceutical company headquartered in Denmark, with a presence in over 50 countries. The company specializes in developing and distributing innovative treatments for brain diseases, leveraging its production facilities in Denmark, France, and Italy, and research centers in Denmark and the United States. Since its listing on Nasdaq Copenhagen in 1999, Lundbeck has been primarily owned by the Lundbeck Foundation, which holds approximately 70% of its shares and supports medical research and educational initiatives. With a history spanning over 70 years, Lundbeck has been instrumental in providing therapies that address neurological and psychiatric disorders, impacting millions of patients worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

21.2%1Y

16.8%3Y

-21.6%5Y

Performance

39.9%1Y

36.1%3Y

34.5%5Y

Volatility

1043 M

Market cap (USD)

78,023

Daily traded volume (Shares)

34 / 33.375

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

UCB SA

UCB SA Valor: 986410

Annual Return

-50%0%+50%

Risk level

110

-1.23%EUR 264.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

3.22%USD 546.89

Demant A/S

Demant A/S Valor: 32651962

Annual Return

-50%0%+50%

Risk level

110

0.88%DKK 195.60

Ambu A/S

Ambu A/S Valor: 39639588

Annual Return

-50%0%+50%

Risk level

110

0.95%DKK 69.05

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

2.21%DKK 40.78

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

1.89%DKK 27.00

Lineage Inc

Lineage Inc Valor: 136372357

Annual Return

-50%0%+50%

Risk level

110

0.46%USD 32.93

Bausch Health Companies Inc

Bausch Health Companies Inc Valor: 42260834

Annual Return

-50%0%+50%

Risk level

110

-3.86%USD 5.37

Dyne Therapeutics Inc

Dyne Therapeutics Inc Valor: 56806425

Annual Return

-50%0%+50%

Risk level

110

4.09%USD 18.84

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc Valor: 22860122

Annual Return

-50%0%+50%

Risk level

110

4.81%USD 22.45

SIX

FactSet

Clearbit

Logos provided by Clearbit